Improving Malaria Treatment in Benin
Author Information
Author(s): Nahum Alain, Erhart Annette, Gazard Dorothée, Agbowai Carine, Van Overmeir Chantal, Loen Harry, Menten Joris, Akogbeto Martin, Coosemans Marc, Massougbodji Achille, D'Alessandro Umberto
Primary Institution: Laboratoire de Parasitologie, Centre de Recherches Entomologique de Cotonou, Cotonou, Bénin
Hypothesis
Does adding artesunate to sulphadoxine-pyrimethamine improve treatment efficacy in children with uncomplicated falciparum malaria?
Conclusion
The combination of artesunate and sulphadoxine-pyrimethamine is effective for treating uncomplicated malaria in Benin.
Supporting Evidence
- The treatment failure rate was significantly lower in the artesunate + sulphadoxine-pyrimethamine group compared to the other groups.
- Fever clearance was faster in the SP-AS group than in the CQ or SP groups.
- By day 28, the PCR-corrected treatment failure rate for the SP-AS group was only 5.3%.
Takeaway
Giving children a mix of two medicines, artesunate and sulphadoxine-pyrimethamine, helps them get better from malaria faster than using just one medicine.
Methodology
A randomized, open-label clinical trial was conducted comparing chloroquine, sulphadoxine-pyrimethamine, and their combination with artesunate in children aged 6-59 months.
Potential Biases
Potential bias in treatment allocation and follow-up due to the open-label design.
Limitations
The study may not be generalizable to other regions due to specific local factors affecting malaria treatment.
Participant Demographics
Children aged 6 to 59 months with uncomplicated malaria from the coastal lagoon area of Benin.
Statistical Information
P-Value
0.001
Confidence Interval
95% CI: 4.3; 58.5
Statistical Significance
p < 0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website